Literature DB >> 25048606

Altered mental status and end organ damage associated with the use of gacyclidine: a case series.

J A Chenoweth1, R R Gerona, J B Ford, M E Sutter, J S Rose, T E Albertson, S O Clarke, K P Owen.   

Abstract

INTRODUCTION: Over the past decade, there has been a sharp increase in the number of newly identified synthetic drugs. These new drugs are often derivatives of previously abused substances but have unpredictable toxicity. One of these drugs is gacyclidine, a derivative of phencyclidine (PCP). Gacyclidine has been studied as a neuroprotective agent in trauma and as a therapy of soman toxicity. There are no previous reports of its use as a drug of abuse. CASE REPORTS: During a two-month period in the summer of 2013, a series of patients with severe agitation and end-organ injury were identified in an urban academic Emergency Department (ED). A urine drug of abuse screen was performed on all patients, and serum samples were sent for comprehensive toxicology analysis. A total of five patients were identified as having agitation, rhabdomyolysis, and elevated troponin (Table 1). Three of the five patients reported use of methamphetamine, and all five patients had urine drug screens positive for amphetamine. Comprehensive serum analysis identified methamphetamine in three cases, cocaine metabolites in one case, and a potential untargeted match for gacyclidine in all five cases. No other drugs of abuse were identified. DISCUSSION: This is the first series of cases describing possible gacyclidine intoxication. The possible source of the gacyclidine is unknown but it may have been an adulterant in methamphetamine as all patients who were questioned reported methamphetamine use. These cases highlight the importance of screening for new drugs of abuse when patients present with atypical or severe symptoms. Gacyclidine has the potential to become a drug of abuse both by itself and in conjunction with other agents and toxicity from gacyclidine can be severe. It is the role of the medical toxicology field to identify new agents such as gacyclidine early and to attempt to educate the community on the dangers of these new drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25048606      PMCID: PMC4371039          DOI: 10.1007/s13181-014-0415-2

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  22 in total

Review 1.  Cocaine and the club drugs.

Authors:  Samuel Demaria; Julia L Weinkauf
Journal:  Int Anesthesiol Clin       Date:  2011

2.  Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support.

Authors:  G Lallement; D Clarençon; M Galonnier; D Baubichon; M F Burckhart; M Peoc'h
Journal:  Arch Toxicol       Date:  1999-03       Impact factor: 5.153

3.  Interaction of gacyclidine enantiomers with 'non-NMDA' binding sites in the rat central nervous system.

Authors:  H Hirbec; J M Kamenka; A Privat; J Vignon
Journal:  Brain Res       Date:  2001-03-16       Impact factor: 3.252

4.  Phencyclidine: a 5-year retrospective review from the New York City Medical Examiner's Office.

Authors:  Stephen J deRoux; Anthony Sgarlato; Elizabeth Marker
Journal:  J Forensic Sci       Date:  2011-02-03       Impact factor: 1.832

Review 5.  The syndrome of excited delirium.

Authors:  James R Gill
Journal:  Forensic Sci Med Pathol       Date:  2014-02-14       Impact factor: 2.007

6.  Sudden death during arrest and phencyclidine intoxication.

Authors:  Joseph P Pestaner; Pamela E Southall
Journal:  Am J Forensic Med Pathol       Date:  2003-06       Impact factor: 0.921

7.  Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.

Authors:  J M Kamenka; B Chiche; R Goudal; P Geneste; J Vignon; J P Vincent; M Lazdunski
Journal:  J Med Chem       Date:  1982-04       Impact factor: 7.446

8.  Early functional outcomes and histological analysis after spinal cord compression injury in rats.

Authors:  Nicolas Lonjon; Pascal Kouyoumdjian; Monica Prieto; Luc Bauchet; Henri Haton; Manuel Gaviria; Alain Privat; Florence E Perrin
Journal:  J Neurosurg Spine       Date:  2010-01

9.  Acute phencyclidine intoxication: clinical patterns, complications, and treatment.

Authors:  M M McCarron; B W Schulze; G A Thompson; M C Conder; W A Goetz
Journal:  Ann Emerg Med       Date:  1981-06       Impact factor: 5.721

10.  Effects of the novel NMDA receptor antagonist gacyclidine on recovery from medial frontal cortex contusion injury in rats.

Authors:  J S Smith; Z L Fulop; S A Levinsohn; R S Darrell; D G Stein
Journal:  Neural Plast       Date:  2000       Impact factor: 3.599

View more
  1 in total

Review 1.  Systematic review of nephrotoxicity of drugs of abuse, 2005-2016.

Authors:  Kanaan Mansoor; Murad Kheetan; Saba Shahnawaz; Anna P Shapiro; Eva Patton-Tackett; Larry Dial; Gary Rankin; Prasanna Santhanam; Antonios H Tzamaloukas; Tibor Nadasdy; Joseph I Shapiro; Zeid J Khitan
Journal:  BMC Nephrol       Date:  2017-12-29       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.